Development and validation of claims-based algorithms to identify interstitial lung disease among Japanese patients with cancer in routine clinical practice using real-world data sources - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Creation and assessment of claims-based algorithms for detecting interstitial lung disease in Japanese cancer patients utilizing real-world data in standard clinical settings

  • By

  • Yu-Jing Huang

  • Toshihiro Takeda

  • Yoshie Shimai

  • Taizo Murata

  • Kento Sugimoto

  • Yoshito Takeda

  • Haruhiko Hirata

  • Makoto Yamamoto

  • Midori Yoneda

  • Seigo Minami

  • Masahiro Higashi

  • Alan James Michael Brnabic

  • Zbigniew Kadziola

  • Tsutomu Kawaguchi

  • Yucherng Chen

  • Yasushi Matsumura

  • September 9, 2026

Share

  • 1

    A claims-based algorithm was developed to identify interstitial lung disease (ILD) in Japanese cancer patients using machine-learning modeling.

  • 2

    The study analyzed data from 13,601 patients, with 415 classified as ILD cases through natural language processing of CT reports.

  • 3

    The LASSO reduced model achieved a sensitivity of 33.5% and specificity of 99.3%, indicating its performance in identifying true-positive ILD cases.

  • 4

    External validation of the algorithm showed a sensitivity of 19.8% and specificity of 99.4%, demonstrating its applicability in different datasets.

  • 5

    The algorithm may assist in case confirmation for retrospective studies evaluating ILD risk associated with various cancer treatments.

Original Source(s)

Related Content